Ignite Creation Date:
2024-05-05 @ 4:41 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00290953
Status:
COMPLETED
Last Update Posted:
2008-12-23
First Post:
2006-02-10
Brief Title:
Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin Etoposide
Sponsor:
Organization:
Sanofi